Skip to Main Content

Paper Details

Qa-1<sup>b</sup> Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.
Mol Cancer Res
9
2021
CD8, CD8+, CD8+ T cells, CD8+ T-cell, CD94, Cas9, HLA-E, MHC complexes, NK cells, NK), NKG2A, PD-1, PD1, Qa-1b, Qa-1b-restricted T-cell receptors, TAP-dependent, TAP1, TAP1-deficient tumors, Treg, Tumors, anti-, anti-PD1, cancer, cytotoxic T cells, deficiency of TAP1, mouse, natural killer (, neutrophils, non-classical MHC class I molecule, patients, regulatory T cells, tumors
Author NameAffiliation
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanCenter for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanCenter for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
  • 1 - 10

Datasets

Release 1.2